| cpd00032 | 2305943-23-9 | lytic peptides | LVKRFKKFFRKLRRCVLL | Pteroic acid | Anticancer therapy, MCF-7 cells | amide | Dai, Yuxuan;et.al (2019)
DOI |
cpd00033 | 2305943-22-8 | lytic peptides | ELVRRFRRFFRRLRRCVLL | Pteroic acid | Anticancer therapy, MCF-7 cells | amide | Dai, Yuxuan;et.al (2019)
DOI | cpd00034 | 2305943-21-7 | lytic peptides | LVKRFKKFFRKLKKCVLL | Fluorescein | Anticancer therapy, MCF-7 cells | amide | Dai, Yuxuan;et.al (2019)
DOI | cpd00035 | 2305943-18-2 | lytic peptides | LVRRFRRFFRRLRRCVLL | Paclitaxel | Anticancer therapy, MCF-7 cells | sulfide | Dai, Yuxuan;et.al (2019)
DOI | cpd00036 | 2305943-17-1 | lytic peptides | LVKRFKKFFRKLKKCVLL | Paclitaxel | Anticancer therapy, MCF-7 cells | sulfide | Dai, Yuxuan;et.al (2019)
DOI | cpd00037 | 2375240-36-9 | dipeptide | XVI | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00038 | 2375240-35-8 | dipeptide | XVF | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00039 | 2375240-34-7 | dipeptide | XAA | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00040 | 2375240-33-6 | dipeptide | XVA | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00041 | 2375240-32-5 | dipeptide | XVG | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00042 | 2375240-31-4 | dipeptide | XIV | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00043 | 2375240-30-3 | dipeptide | XFV | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00044 | 2375240-29-0 | dipeptide | XGV | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00045 | 2375240-28-9 | dipeptide | XAV | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00046 | 2375240-27-8 | dipeptide | XVV | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00047 | 2375240-26-7 | dipeptide | XVI | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00048 | 2375240-25-6 | dipeptide | XVF | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00049 | 2375240-24-5 | dipeptide | XAA | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00050 | 2375240-23-4 | dipeptide | XVA | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00051 | 2375240-22-3 | dipeptide | XVG | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00052 | 2375240-21-2 | dipeptide | XIV | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00053 | 2375240-20-1 | dipeptide | XFV | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00054 | 2375240-19-8 | dipeptide | XGV | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00055 | 2375240-18-7 | dipeptide | XAV | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00056 | 2375240-17-6 | dipeptide | XVV | Curcumin | Anticancer therapy, HepG2 and SMMC-7721 cells | amide | Zhang, Jiyun;et.al (2019)
DOI | cpd00057 | 2265215-79-8 | tripeptide | XVVX | N-(4-Hydroxyphenyl)-N-methylethenesulfonamide | Synthesis, cysteine-Selective conjugation to prepare antibody-drog conjugates | amide | Huang, Rong;et.al (2018)
DOI | cpd00058 | 2265215-71-0 | tripeptide | XVVX | N-(4-Hydroxyphenyl)-N-methylethenesulfonamide | Synthesis, cysteine-Selective conjugation to prepare antibody-drog conjugates | amide | Huang, Rong;et.al (2018)
DOI | cpd00059 | 2247229-89-4 | model peptide | LFMSCRTWKHYEQ | N-(4-Hydroxyphenyl)-N-methylethenesulfonamide | Synthesis, cysteine-Selective conjugation to prepare antibody-drog conjugates | sulfide | Huang, Rong;et.al (2018)
DOI | cpd00060 | 2247055-91-8 | tripeptide | XVVX | 2-[2-(2-Azidoethoxy)ethoxy]acetic acid | Synthesis, cysteine-Selective conjugation to prepare antibody-drog conjugates | amide | Huang, Rong;et.al (2018)
DOI | cpd00061 | 2247055-90-7 | tripeptide | XVVX | 2-[2-(2-Azidoethoxy)ethoxy]acetic acid | Synthesis, cysteine-Selective conjugation to prepare antibody-drog conjugates | amide | Huang, Rong;et.al (2018)
DOI |